Articles On Alchemia (ASX:ACL)
Title | Source | Codes | Date |
---|---|---|---|
Blood is thicker this quarter: Part 2. Healius
The biomedical treatment of disease and injury is what we call Pathology. Needles. Blood. Tissue. Other gross things. Etc. From the commonplace lab services which take and test our blood – to the cutting edge biological research of medical... |
Stockhead | ACL | 1 day ago |
Blood is thicker this quarter: Morningstar’s pathological outliers. Part 1. Sonic Healthcare
The biomedical treatment of disease and injury is what we call Pathology. Needles. Blood. Tissue. Other gross things. Etc. From the common place lab services which take and test our blood – to the cutting edge biological research of medical... |
Stockhead | ACL | 2 days ago |
Mixed economic signals weigh on US markets
US stocks slid as mixed economic data raised fears that stagflation may rear its ugly head, as growth numbers came in weaker than expected and price growth higher than expected. The Dow Jones fell 0.98 per cent. The S&P 500 closed dow... |
ShareCafe | ACL | 2 weeks ago |
Mixed economic signals weigh on markets
US stocks slid as mixed economic data raised fears that stagflation may rear its ugly head, as growth numbers came in weaker than expected and price growth higher than expected. The Dow Jones fell 0.98 per cent. The S&P 500 closed down... |
ShareCafe | ACL | 2 weeks ago |
These are the 10 most shorted ASX shares
At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels... |
Motley Fool | ACL | 1 month ago |
These are the 10 most shorted ASX shares
At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high level... |
Motley Fool | ACL | 1 month ago |
S&P 500 sets new high as market bounces back
US markets bounced back after three consecutive losing sessions & extended their first quarter advance. The S&P 500 closed at a new record high finishing the day up 0.86 per cent at 5,248. The Dow Jones closed up 1.2 per cent and... |
ShareCafe | ACL | 1 month ago |
S&P 500 sets new high as market bounces back
US markets bounced back after three consecutive losing sessions & extended their first quarter advance. The S&P 500 closed at a new record high finishing the day up 0.86 per cent at 5,248. The Dow Jones closed up 1.2 per cent and th... |
ShareCafe | ACL | 1 month ago |
These are the 10 most shorted ASX shares
At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high level... |
Motley Fool | ACL | 1 month ago |
Shares vs. property: Why cheaper homes and ASX small-cap shares are rising fastest in 2024
Cheaper homes and ASX small-cap shares are delivering superior capital growth to investors in 2024, new figures show. ASX small-cap shares are defined as companies with a market capitalisation of between a few hundred thousand and $2 bill... |
Motley Fool | ACL | 1 month ago |
These are the 10 most shorted ASX shares
At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high level... |
Motley Fool | ACL | 1 month ago |
These are the 10 most shorted ASX shares
At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high level... |
Motley Fool | ACL | 2 months ago |
2 ASX 300 shares crashing up to 12% on earnings updates
It has been another busy day of earnings releases on Wednesday. Some results have gone down well with investors, others have not. For example, listed below are two ASX 300 shares that are being sold off following the release of their respe... |
Motley Fool | ACL | 2 months ago |
2 ASX healthcare shares with 'compelling' valuations to buy
It's fair to say that ASX healthcare shares have flummoxed investors over the past couple of years. As interest rates headed up and consumers closed their wallets, many fund managers expected the health sector to outperform because of the... |
Motley Fool | ACL | 3 months ago |
3 'attractive' small-cap ASX shares ready to rocket in 2024
After two years of shocking underperformance, ASX small-cap shares made a stunning comeback towards the end of 2023. "Despite the negativity that pervaded most of last year, the small cap market ultimately managed to deliver solid returns... |
Motley Fool | ACL | 3 months ago |
This ASX healthcare share just hit a 52-week low, is it time to buy?
ASX healthcare share Australian Clinical Labs Ltd (ASX: ACL) has seen a large sell-off this year. So is this an opportunity to buy the dip? As we can see on the chart below, since March 2023, the Australian Clinical Labs share price has sh... |
Motley Fool | ACL | 6 months ago |
Australia’s privacy watchdog launches legal action against Australian Clinical Labs
The nation’s privacy watchdog has launched civil proceedings against Australian Clinical Labs (ASX: ACL) over a Medlab hack that saw more than 223,000 patients and staff have their health records and credit card numbers stolen late last yea... |
businessnewsaustralia.com | ACL | 6 months ago |
2 ASX shares that could EXPLODE when their M&A deals are done
One of the biggest potential reasons for massive price movement in an ASX stock is mergers and acquisitions. That's because, in an instant, the nature of the whole business can change. If it's offloading an unprofitable activity, then the... |
Motley Fool | ACL | 7 months ago |
The Match Out: Huge intra-day bounce as buyers emerge with force
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.051% to 7068.80. Markets @ Midday: Listen here at lunchtime or find all Market Matters Podcasts on Spotify... |
Rask Media | ACL | 7 months ago |
Short & Caught: Pilbara Minerals in the crosshairs as lithium plays targeted
Pilbara Minerals has become the most shorted ASX stock as price of lithium falls from 2022 highs Flight Centre the second most shorted ASX stock, despite a turnaround in its profits in FY23 AI play Brainchip Holdings booted from S&P AS... |
Stockhead | ACL | 7 months ago |
The Match Out: ASX 200 climbs on resources
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.46% to 7186.50. Markets @ Midday: Listen here at lunchtime or find all Market Matters Podcasts on Spotify.... |
Rask Media | ACL | 8 months ago |
ASX Large Caps: Iron ore, uranium, coal stocks rally; Aussie job market blows away forecast
The ASX 200 climbed on Thursday Iron ore, uranium, and coal stocks mostly rallied Australian employment rate held steady in August, blowing past forecasts Local shares climbed on Thursday as the labour market data blew past predictions.... |
Stockhead | ACL | 8 months ago |
ACL’s $1.58b merger with Healius hits a snag as ACCC decision looms
The $1.58 billion off-market takeover bid for pathology company Healius (ASX: HLS) has been put on hold by Australian Clinical Labs (ASX: ACL) pending a decision by the competition watchdog and a review of the target’s FY23 financial statem... |
businessnewsaustralia.com | ACL | 8 months ago |
Dow falls as core inflation data is higher than expected
The Dow Jones Industrial Average fell Wednesday as traders absorbed a hotter-than-expected August core inflation print. The Dow lost 70.46 points, or 0.20 per cent, to 34,575.53 for its second straight decline. Meanwhile, the S&P 500... |
ShareCafe | ACL | 8 months ago |
The Match Out: S&P/ASX 200 (INDEXASX:XJO) falls ahead of key US inflation data
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down 0.74% to 7153.90. Markets @ Midday: Listen here at lunchtime or find all Market Matters Podcasts on Spotify... |
Rask Media | ACL | 8 months ago |
Healius share price rises strongly despite 92% profit crash in FY23
The Healius Ltd (ASX: HLS) share price finished the session on Wednesday up 7.75% after the company released its full-year FY23 results. Healius reported an underlying profit of just $25.7 million, which is a 91.6% fall year over year. De... |
Motley Fool | ACL | 8 months ago |
3 ASX All Ords shares falling hard on earnings updates
It’s been a mildly pleasant day for the All Ordinaries Index (ASX: XAO) and most ASX All Ords shares so far today. This Tuesday has seen the All Ords add 0.1% at the time of writing. But let’s talk about three All Ords shares that aren’t f... |
Motley Fool | ACL | 8 months ago |
Competition watchdog notes "strong concerns" over ACL, Healius merger
The Australian Competition and Consumer Commission (ACCC) is wary of the possible market impact if two of the country's largest pathology companies Australian Clinical Labs Limited (ASX: ACL) and Healius (ASX: HLS) join forces, particularly... |
businessnewsaustralia.com | ACL | 9 months ago |
ASX Health Stocks: BPH wants to ramp up bird’s nest sales to China
BPH Global about to ramp up China business ACL faces ACCC resistance on proposed takeover of Healius BPH Global to expand China business Health & wellness stock BPH Global (ASX:BP8) rose 20% after flagging a potential ramp up in Chi... |
Stockhead | ACL | 9 months ago |
The ACCC highlights competition concerns over ACL’s (ASX:ACL) proposed acquisition of Healius (ASX:HLS)
The Australian Competition and Consumer Commission (ACCC) has dealt a blow to ACL’s (ACL) proposed acquisition of Healius (HLS), highlighting preliminary competition concerns over the merger. The ACCC released a statement of issues today... |
themarketherald.com.au | ACL | 9 months ago |
Fundie reveals ASX 300 healthcare stock trading at 40% discount to peers
If youâre on the lookout for bargain buys, then you may want to check out Australian Clinical Labs Ltd (ASX: ACL) shares. Thatâs because one fund manager believes the ASX 300 healthcare stock is trading at a mouth-watering discount. Th... |
Motley Fool | ACL | 11 months ago |
Check Up: Here’s the handful of ASX small cap health stocks that actually pay dividends
Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week When we talk about dividend-paying hea... |
Stockhead | ACL | 11 months ago |
Australian Clinical Labs claims merger target Healius is ‘failing’ shareholders
A bid from Australian Clinical Labs (ASX: ACL) to merge with pathology services business Healius (ASX: HLS) has escalated into a slinging match, with the suitor now claiming the target is ‘failing’ shareholders by not recommending its $1.58... |
businessnewsaustralia.com | ACL | 11 months ago |
3 magnificent ASX dividend shares that could turn $5k into $50,000
There is an impression among many investors that big riches can only be achieved with ASX growth shares. But that can’t be further from the truth. There are multiple paths to the promised land. The fact is that strong returns are possible... |
Motley Fool | ACL | 11 months ago |
12 ASX dividend shares with yields over 10%. Are they too good to be true?
The ASX boards are home to hundreds of shares. And many of them pay out dividends to their investors every year. The relationship between the dividends per share that a company pays and the price that a company’s shares trade at produces t... |
Motley Fool | ACL | 1 year ago |
Weaker financial sector hits markets: Google and Alphabet rise afterhours
ShareCafeWeaker financial sector hits markets: Google and Alphabet rise afterhours Stocks slid Tuesday after First Republic Bank’s earnings report reignited concerns about the broader sector. Pressure on the sector... |
ShareCafe | ACL | 1 year ago |
The Ethical Investor: Why Australian Ethical Investment dumped Lendlease, but loves Woolies
The Australian Ethical Investment has divested its Lendlease holding The ESG-focused fundie explains why it invests in certain sectors The AEF also provides some ASX stock recommendations for ethical investors ESG-focused fund manager A... |
Stockhead | ACL | 1 year ago |
MoneyTalks: Why Tribeca believes the tide is turning for ASX small caps, and their top three picks
MoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We’ll tap our extensive list of experts to hear what’s hot, their top picks, and what they’re looking out for. Today we hear from Tribeca Inve... |
Stockhead | ACL | 1 year ago |
Which ASX All Ords healthcare share has a 20% dividend yield?
There’s a little-known ASX All Ords share currently trading on a staggering 20% gross trailing dividend yield. This company is a small-cap among ASX healthcare shares with a market capitalisation of $712 million. It’s pathology services... |
Motley Fool | ACL | 1 year ago |
Healius (ASX:HLS) dealt blow as Takeovers Panel sees no issue with ACL’s (ASX:ACL) off-market bid
Healius (HLS) is dealt a blow as the Takeovers Panel decides against conducting proceedings over Australian Clinical Labs’ (ACL) off-market proposal last month Healius, Australia’s second-largest pathology provider, says there are “a num... |
themarketherald.com.au | ACL | 1 year ago |
Healius takes ‘misleading’ Australian Clinical Labs proposal to Takeovers Panel
The conditions of a $1.58 billion bid from Australian Clinical Labs (ASX: ACL) are ‘overly restrictive and burdensome’ according to target Healius Limited (ASX: HLS), which has approached the Takeovers Panel for intervention in the matter.... |
businessnewsaustralia.com | ACL | 1 year ago |
2 ASX healthcare shares to buy for defensive earnings (one big, one cap)
ASX healthcare shares have underperformed the broader market since the pandemic-induced market lows in March 2020. Over the last three years, the S&P/ASX 200 Healthcare index has returned just 5.5% per year compared to the S&P/ASX 2... |
Rask Media | ACL | 1 year ago |
Healius (ASX:HLS) reaffirms “no-action” stance regarding takeover proposal from ACL (ASX:ACL)
Healius (HLS) reaffirms its “no action” stance to shareholders in relation to an off-market takeover bid from Australian Clinical Labs (ACL) on March 20 ACL says the merger, if it comes to fruition, could create Australia’s largest patho... |
themarketherald.com.au | ACL | 1 year ago |
ASX Large Caps: Latitude’s cyber theft 40x bigger than first thought; expert says investors could rotate from safe stocks
The ASX finished flattish on Monday Energy stocks lagged, while Utilities and Real Estate led There’s a host of key releases in Australia this week, including CPI data on Wednesday The ASX 200 closed flattish on Monday with losses in th... |
Stockhead | ACL | 1 year ago |
Deutsche Bank the latest international bank to tumble
ShareCafeDeutsche Bank the latest international bank to tumble Stocks rose Friday after a volatile trading session. Although Friday began with fears that the banking crisis was spilling over to Deutsche Bank, the ma... |
ShareCafe | ACL | 1 year ago |
ScoPo’s Powerplays: ASX health stocks fall, Healius receives $1.52 billion takeover offer
ASX health stocks fall 0.9% in the past five days Healius receives a $1.52 billion takeover offer from Australian Clinical Labs Pharmaceutical wholesaler Sigma reports improved performance for the financial year Healthcare and life scien... |
Stockhead | ACL | 1 year ago |
Why Brickworks, Healius, Mincor, and Northern Star shares are rising today
The S&P/ASX 200 Index (ASX: XJO) is having a disappointing session on Thursday. In afternoon trade, the benchmark index is down 0.7% to 6,966.7 points. Four ASX shares that are not letting that hold them back are listed below. Hereâ... |
Motley Fool | ACL | 1 year ago |
ASX closes 1.38% lower as investors digest Credit Suisse takeover
ShareCafeASX closes 1.38% lower as investors digest Credit Suisse takeover by Peter Milios On Monday, at the closing bell, the S&P/ASX 200 was 1.38 per cent lower at 6,898.50, as investors considered the takeover of Credit Suisse and... |
ShareCafe | ACL | 1 year ago |
Healius [ASX:HLS] Receives Buyout Offer from ACL [ASX:ACL]
Australian Clinical Labs has put an offer to Healius to swap shares in an off-market takeover offer. The post Healius [ASX:HLS] Receives Buyout Offer from ACL [ASX:ACL] appeared first on Money Morning Australia. |
MoneyMorning | ACL | 1 year ago |
ASX Large Caps: Shares sharply down over bank angst, gold shares still go-to haven
ASX accelerated losses in the afternoon, closing over 1% lower Healthcare stock Healius gets takeover bid from a much smaller company Market places 25% chance the Fed will pause this week The ASX 200 index finished almost 1.5% lower on... |
Stockhead | ACL | 1 year ago |